HCPCS Level II
J9395
Injection, fulvestrant, 25 mg
Codes near J9395
These sit next to J9395 in the CMS Level II file. All J codes
- J9381Injection, teplizumab-mzwv, 5 mcg
- J9382Injection, zenocutuzumab-zbco, 1 mg
- J9390Injection, vinorelbine tartrate, 10 mg
- J9393Injection, fulvestrant (teva), not therapeutically equivalent to j9395, 25 mg
- J9394Injection, fulvestrant (fresenius kabi) not therapeutically equivalent to j9395, 25 mg
- J9400Injection, ziv-aflibercept, 1 mg
- J9600Injection, porfimer sodium, 75 mg
- J9601Injection, linvoseltamab-gcpt, 1 mg
- J9999Not otherwise classified, antineoplastic drugs
NDC crosswalk
| NDC | Drug | Labeler | Billable units |
|---|---|---|---|
| 00143-9022-02 | Fulvestrant | Hikma Pharmaceuticals USA Inc. | 20 |
| 00310-0720-10 | Faslodex | AstraZeneca Pharmaceuticals LP | 20 |
| 00781-3532-12 | Fulvestrant | Sandoz Inc. | 20 |
| 00781-9055-12 | Fulvestrant | Sandoz Inc. | 20 |
| 16714-0070-02 | Fulvestrant | Northstar RxLLC | 20 |
| 16729-0436-30 | Fulvestrant | Accord Healthcare Inc | 20 |
| 25021-0462-74 | Fulvestrant | Sagent Pharmaceuticals | 20 |
| 25021-0471-74 | Fulvestrant | Sagent Pharmaceuticals | 20 |
| 43598-0262-02 | Fulvestrant | Dr. Reddy's Laboratories Inc. | 20 |
| 43598-0262-23 | Fulvestrant | Dr. Reddy's Laboratories Inc. | 20 |
| 55150-0394-02 | Fulvestrant | Eugia US LLC | 20 |
| 62332-0650-10 | Fulvestrant | Alembic Pharmaceuticals Inc. | 20 |
| 63323-0715-05 | Fulvestrant | FreseniUS Kabi USA, LLC | 20 |
| 68001-0484-85 | Fulvestrant | BluePoint Laboratories | 20 |
| 68001-0522-85 | Fulvestrant | BluePoint Laboratories | 20 |
| 68001-0626-85 | Fulvestrant | BluePoint Laboratories | 20 |
| 70121-1463-02 | Fulvestrant | Amneal Pharmaceuticals, LLC | 20 |
| 70700-0284-98 | Fulvestrant | Xiromed, LLC | 20 |
| 70710-1688-08 | Fulvestrant | Zydus Pharmaceuticals (USA) Inc. | 20 |
| 70860-0211-74 | Fulvestrant | Athenex Pharmaceutical Division, LLC | 20 |
| 71288-0555-86 | Fulvestrant | Meitheal Pharmaceuticals Inc. | 20 |
| 83634-0203-74 | Fulvestrant | Avenacy Inc. | 20 |
Source: CMS ASP NDC-HCPCS crosswalk, effective October 1, 2026 through December 31, 2026.